Patents

US 12721900 B2: Non-viral immuno-targeting

Granted
2026-09-01
Filed
2020-07-09 application 17625722
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure provides compositions and methods for delivering a payload to cells or tissues that express GLUT4. In some embodiments, the compositions comprise an antibody, or fragment or derivative thereof, that specifically binds to glucose transporter 4 (“GLUT4”) protein, and a therapeutic payload conjugated thereto. In some exemplary embodiments, the compositions are useful for methods of treating a disease or condition in a subject with a genetic mutation in a gene encoding dystrophin protein, wherein the payload comprises a nucleic acid encoding a functional dystrophin protein or functional fragment thereof to ameliorate aspects of the disease.

Source: PTBLXML, file of 2026-09-01 (ipgb20260901.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
University of Washington 1,041 patentsUS company or organizationSeattle, WAUNIVERSITY OF WASHINGTON State business registration EXACT high confidence: identical full name and state
UNIVERSITY OF WASHINGTON Federal lobbying client EXACT high confidence: identical full name and state
UNIVERSITY OF WASHINGTON Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-09-01

Inventors

InventorPlacePatentsPerson pageSource
Nicholas P. WhiteheadSeattle, WA2PTBLXML, file of 2026-09-01
Stanley C. FroehnerSeattle, WA2PTBLXML, file of 2026-09-01

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K47/6849PTBLXML, file of 2026-09-01
C07KPeptidesC07K16/28PTBLXML, file of 2026-09-01

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-04-13Government interest
Confirmatory license
UNIVERSITY OF WASHINGTON signed 2026-04-10THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE DIRECTOR OF THE DEFENSE HEALTH AGENCY FORT DETRICK, MD75379/613PASDL, file of 2026-09-26

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.